Literature DB >> 5439606

[The capillary enzyme barrier for DOPA at the level of some brain stem nuclei in the rat].

J Constantinidis, G Bartholini, F Geissbühler, R Tissot.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5439606     DOI： 10.1007/bf01896900

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


× No keyword cloud information.
  7 in total

Review 1.  Parkinson's disease and levodopa. A five-year follow-up and review.

Authors:  C H Markham; L J Treciokas; S G Diamond
Journal:  West J Med       Date:  1974-09

2.  Treatment of Parkinson's disease with L-DOPA and decarboxylase inhibitor.

Authors:  U K Rinne; V Sonninen; T Sirtola
Journal:  Z Neurol       Date:  1972

3.  Formation of noradrenaline in the rat brain from the four stereoisomers of 3,4-dihydroxyphenylserine.

Authors:  M Puig; G Bartholini; A Pletscher
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

4.  Parkinson's disease and striatal dopamine: in vivo morphological evidence for the presence of dopamine in the human brain.

Authors:  J Constantinidis; J Siegfried; T L Frigyesi; R Tissot
Journal:  J Neural Transm       Date:  1974       Impact factor: 3.575

5.  [Comparison of the effect of L-Dopa and of an L-Dopa+decarboxylase inhibitor combination in Parkinson's disease].

Authors:  E Schneider; P A Fischer; P Jacobi; H Maxion
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1973-03-19

Review 6.  Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

7.  Kantamaneni BD, Curzon G:Comparison of benefit from L-dopa in Parkinsonism with increase of amine metabolites in the CSF.

Authors:  R B Godwin-Austen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1971-06       Impact factor: 10.154
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.